Home » Trials » SLCTR/2017/013


Effectiveness of Diclofenac Sodium as a pre-emptive analgesic for gynecological laparoscopic surgery: a Randomized Controlled Clinical Trial

-

SLCTR Registration Number

SLCTR/2017/013


Date of Registration

20 May 2017

The date of last modification

Mar 03, 2019



Application Summary


Scientific Title of Trial

Effectiveness of Diclofenac Sodium as a pre-emptive analgesic for gynecological laparoscopic surgery: a Randomized Controlled Clinical Trial


Public Title of Trial

Effectiveness of painkillers given before surgery to minimize post-surgical pain


Disease or Health Condition(s) Studied

Post-operative pain


Scientific Acronym

None


Public Acronym

None


Brief title

None


Universal Trial Number

U1111-1194-2407


Any other number(s) assigned to the trial and issuing authority

03/17 (ERC: Sri Jayewardenepura)


Trial Details


What is the research question being addressed?

What is the effectiveness of diclofenac sodium suppositories in pain relief when given pre-emptively as opposed to post-operatively in women undergoing gynaecological laparoscopic surgeries?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Double blinded


Control

Standard therapy/practice


Assignment

Parallel


Purpose

Prevention


Study Phase

Phase 4


Intervention(s) planned

The study will be carried out at ward 23, Colombo South Teaching Hospital (CSTH).

Participants meeting the inclusion/exclusion criteria will be allocated to the study arms using computer generated random numbers.

Arm A (intervention arm) will receive a single rectal administration of diclofenac sodium 100mg (suppository) 30 minutes prior to the procedure. A single rectal administration of an identical matching placebo (suppository) will be given immediate post-operatively.

Arm B (control arm) will receive a single rectal administration of the placebo (suppository) 30 minutes prior to the procedure. A single rectal administration of diclofenac sodium 100mg (suppository) will be given immediate post-operatively.

Standard of care: All patients will be receive general anesthesia and will be given the standard weight calculated doses of same IV pain relief preparations during the surgery. If any of the subjects of either group develop pain they will be adequately provided with postoperative analgesia according to standard unit protocols (IV pethidine, IV / oral tramadol or diclofenac sodium suppositories).

Patients and outcome assessors will be blinded to the intervention status.


Inclusion criteria

  1. Females
  2. Aged between 20 - 65 years
  3. Admitted to the study setting for major and minor laparoscopic gynaecological surgery, under general anaesthesia

Exclusion criteria

  1. Surgical complications such as bowel, bladder or ureter damage
  2. Diagnosed psychiatric illness
  3. Long-term analgesic use
  4. Patients on concomitant medication known to have interactions with NSAIDs
  5. Known allergy or any other contraindication to diclofenac sodium or any other NSAID


Primary outcome(s)

1.

Post-operative pain severity, assessed using a combination of visual analogue scale with Wong-Baker faces.

[

At 2 hours, 6 hours and 24 hours post operatively

]
2.

Need for rescue analgesia

[

During the first 24 hours post-operatively

]

Secondary outcome(s)

1.

None

[

None

]

Target number/sample size

40 (20 in each arm)


Countries of recruitment

Sri Lanka


Anticipated start date

2017-06-01


Anticipated end date

2017-09-25


Date of first enrollment

2017-05-24


Date of study completion


Recruitment status

Recruiting


Funding source

None (Investigator funded)


Regulatory approvals

Not applicable



State of Ethics Review Approval


Status

Approved


Date of Approval

2017-03-23


Approval number

03/17


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medical Sciences, University of Sri Jayewardenepura
Institutional Address:Gangodawila, Nugegoda Sri Lanka
Telephone:+94-112758000 (Extension: 4075)
Email: erc.fms.usjp@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Dr. Jeewaka Wickramasinghe
Registrar in Obstetrics and Gynecology
Colombo South Teaching Hospital Kalubowila, Sri Lanka
Tel: 0112763262
Mob: 0772629192

jeewakabw@yahoo.co.uk

Contact Person for Public Queries

Dr. Dhammike Silva
Consultant Obstetrician and Gynaecologist
Professorial Gynaecology Unit Colombo South Teaching Hospital Kalubowila, Sri Lanka
Tel: 0112763262




Primary study sponsor/organization

Professorial Gynaecology Unit Colombo South Teaching Hospital

Kalubowila, Sri Lanka
Tel: 011 2 763064


Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description

Not Available


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results